BMRN– BioMarin Pharmaceutical Inc evelops and commercializes pharmaceuticals for various diseases and medical conditions.
BMRN– BioMarin Pharmaceutical Inc
|Fundamentals||Previously closed at||89.65|
|Analysts opinion||BioMarin is a specialist in rare-disease specialist. The controversial drug Kyndrisa, which intended to treat Duchenne muscular dystrophy was rejected by the Committee for Medical Products for Human Use (CHMP). Analyst confidence meter, a proprietary algorithm of Stockal gives 89% buy based on analyst ratings.|
|Sentiments||The sentiment index is 50% positive according to Stockal proprietary algorithm.|
|NA Media Pulse||The stock has 64% higher social media chatter than usual.|
CRM – Salesforce.com Inc is a provider of enterprise cloud computing solutions, with a focus on customer relationship management.
CRM – Salesforce.com Inc
|Fundamentals||Previously closed at||83.71|
|Analyst opinion||Salesforce announced that it would buy e-commerce specialist Demandware in a $2.8 Billion deal. Salesforce President Keith Block said that the new E-commerce cloud will join Salesforce’s existing Sales, Marketing, Service and the upcoming IoT clouds. Confidence Meter reads a 75% buy. This a proprietary algorithm of Stockal tracks Analyst confidence in the Stock.|
|Sentiments||The sentiment index is 100% positive on Stockal proprietary algorithm.|
|Social Media Pulse||The stock has 54% higher social chatter than usual.|
Disclaimer: This blog contains an aggregated view of analysts and opinions by the author. Do not consider this as financial advice. See http://stockal.com/legalities/